RENO, Nev. & SAN DIEGO--(BUSINESS WIRE)--Hamilton and Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a strategic co-marketing ...
Collaboration integrates the nRichDX Revolution Plus™ Sample Prep System with the Hamilton Microlab STAR ® platform, delivering automated, high-yield liquid biopsy workflows for cfDNA, cfRNA, cfTNA, ...
The MarketWatch News Department was not involved in the creation of this content. Collaboration integrates the nRichDX Revolution Plus(TM) Sample Prep System with the Hamilton Microlab STAR(R) ...
Hamilton and Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a strategic co-marketing agreement aimed at streamlining automated ...
SAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- Biofluidica, Inc., and Hamilton Company, today announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories worldwide.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果